Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

BAY12-8039: 5 Days for Sinusitis vs Placebo

ClinicalTrials.gov ID: NCT00492024

Public ClinicalTrials.gov record NCT00492024. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prospective, Multicenter, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Moxifloxacin 400 mg QD for 5 Days Versus Placebo in the Treatment of Acute Bacterial Sinusitis

Study identification

NCT ID
NCT00492024
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
374 participants

Conditions and interventions

Conditions

Interventions

  • Moxifloxacin (Avelox, BAY12-8039) Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2004
Primary completion
Feb 29, 2008
Completion
Feb 29, 2008
Last update posted
Nov 25, 2013

2005 – 2008

United States locations

U.S. sites
51
U.S. states
22
U.S. cities
48
Facility City State ZIP Site status
Not listed Birmingham Alabama 35209
Not listed Northport Alabama 35476
Not listed Jonesboro Arkansas 72401
Not listed Little Rock Arkansas 72205
Not listed Fresno California 93710
Not listed Fresno California 93720
Not listed Garden Grove California 92840
Not listed Orange California 92868
Not listed Roseville California 95678
Not listed San Diego California 92106
Not listed San Luis Obispo California 93405
Not listed Colorado Springs Colorado 80909
Not listed Bridgeport Connecticut 06606
Not listed Dunnellon Florida 34432
Not listed Hialeah Florida 33013
Not listed North Miami Beach Florida 33179
Not listed Pembroke Pines Florida 33024
Not listed Plantation Florida 33324
Not listed Atlanta Georgia 30310
Not listed Warner Robbins Georgia 31093
Not listed Warner Robins Georgia 31088
Not listed Louisville Kentucky 40207
Not listed Detroit Michigan 48202
Not listed Livonia Michigan 48152
Not listed Portage Michigan 49024
Not listed Butte Montana 59701
Not listed Elizabeth New Jersey 07202-3672
Not listed Lawrenceville New Jersey 08698
Not listed Somerville New Jersey 08876
Not listed Rochester New York 14618
Not listed Charlotte North Carolina 28210
Not listed Raleigh North Carolina 27609
Not listed Cincinnati Ohio 45241
Not listed Dayton Ohio 45406
Not listed Eugene Oregon 97404
Not listed Levittown Pennsylvania 19056
Not listed Norristown Pennsylvania 19401
Not listed Palmyra Pennsylvania 17078
Not listed Clarksville Tennessee 37043
Not listed Austin Texas 78705
Not listed College Station Texas 77845
Not listed El Paso Texas 79904
Not listed Houston Texas 77074
Not listed San Antonio Texas 78229
Not listed Salt Lake City Utah 84109
Not listed Salt Lake City Utah 84121
Not listed West Jordan Utah 84084
Not listed West Jordan Utah 84088
Not listed Tappahannock Virginia 22560
Not listed Bellingham Washington 98225
Not listed Greenfield Wisconsin 53228

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00492024, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 25, 2013 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00492024 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →